Toward a robust monitoring of HIV subtypes distribution worldwide

AIDS

Volumn 25, Issue 5, 2011, Pages 713-714

  Salemi, Marco ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

EDITORIAL; EPIDEMIC; GENETIC VARIABILITY; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNIZATION; INCIDENCE; MONITORING; NONHUMAN; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; VIRUS ISOLATION; VIRUS RECOMBINATION; VIRUS REPLICATION; WORLD HEALTH ORGANIZATION;

FEMALE; GENETIC VARIATION; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOLECULAR EPIDEMIOLOGY; WORLD HEALTH;

EID: 79952412909     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32834543e7     Document Type: Editorial

References (16)

1. Hemelaar J, Gouws E, Ghys PD, Osmanov S, WHO-AIDS Network for HIV Isolation and Characterisation. Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 2011; 25:679-689.
2. Arien KK, Vanham G, Arts EJ. Is HIV-1 evolving to a less virulent form in humans? Nat Rev Microbiol 2007; 5:141-151. (Pubitemid 46151872)
3. Brown T, Salomon JA, Alkema L, Raftery AE, Gouws E. Progress and challenges in modelling country-level HIV/AIDS epidemics: the UNAIDS Estimation and Projection Package 2007. Sex Transm Infect 2008; 84 (Suppl 1):i5-i10.
4. Stover J, Johnson P, Zaba B, Zwahlen M, Dabis F, Ekpini RE. The Spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds. Sex Transm Infect 2008; 84 (Suppl 1):i24-i30.
5. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009; 361:2209-2220.
6. Bansal GP, Malaspina A, Flores J. Future paths for HIV vaccine research: exploiting results from recent clinical trials and current scientific advances. Curr Opin Mol Ther 2010; 12: 39-46.
7. Lutalo T, Gray RH, Wawer M, Sewankambo N, Serwadda D, Laeyendecker O, et al. Survival of HIV-infected treatmentnaive individuals with documented dates of seroconversion in Rakai, Uganda. AIDS 2007; 21 (Suppl 6):S15-S19. (Pubitemid 350158884)
8. Vasan A, Renjifo B, Hertzmark E, Chaplin B, Msamanga G, Essex M, et al. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin Infect Dis 2006; 42:843-852. (Pubitemid 43363943)
9. Kiwanuka N, Laeyendecker O, Quinn TC, Wawer MJ, Shepherd J, Robb M, et al. HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda. AIDS 2009; 23:2479-2484.
10. Anthony I, Ramage S, Carnie F, Simmonds P, Bell J. Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol 2005; 64:529-536. (Pubitemid 40781156)
11. Bell J. An update on the neuropathology of HIV in the HAART era. Histopathology 2004; 45:549-559. (Pubitemid 40029814)
12. Liner KJ 2nd, Hall CD, Robertson KR. Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease. J Neurovirol 2007; 13:291-304. (Pubitemid 47400028)
13. Korber B, Muldoon M, Theiler J, Gao F, Gupta R, Lapedes A, et al. Timing the ancestor of the HIV-1 pandemic strains. Science 2000; 288:1789-1796. (Pubitemid 30399011)
14. Salemi M, Strimmer K, Hall WW, Duffy M, Delaporte E, Mboup S, et al. Dating the common ancestor of SIVcpz and HIV-1 group M and the origin of HIV-1 subtypes using a new method to uncover clock-like molecular evolution. FASEB J 2001; 15: 276-278.
15. Worobey M, Gemmel M, Teuwen DE, Haselkorn T, Kunstman K, Bunce M, et al. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 2008; 455:661-664.
16. Gray RR, Tatem AJ, Lamers SL, Hou W, Laeyendecker O, Serwadda D, et al. Spatial phylodynamics of HIV-1 epidemic emergence in east Africa. AIDS 2009; 23:F9-F17.